Ionis Pharmaceuticals
IONS
44.16
+0.16
+0.36%
Ionis Pharmaceuticals
US · IONS
#1749 by market cap
Listed 1970
44.16
+0.16
+0.36%
Live - 5344 symbols - heartbeat 508s ago
· 2026-10-08 08:19
Pre-market
44.03
-0.29%
After-hours
44.16
0.00%
- Market cap
- 7.34B
- P/E (TTM)i
- -12.69
- P/Bi
- 16.69
- EPSi
- -2.38
- Div yieldi
- 0.00%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on IONS?
Anonymous reader poll. Unscientific, not investment advice.
About Ionis Pharmaceuticals
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
- Founded
- 1989
- CEO
- Dr. Brett P. Monia, PhD
- Employees
- 1,402
- Headquarters
- Carlsbad, California, United States of America
- Fiscal year end
- 12-31
- Website
- ionis.com
Company profile
- Exchange
- US
- Symbol
- IONS
- Market-cap rank
- #1749
- Listing date
- 1970-01-01
- Market cap
- 7.34B
- Float cap
- 7.28B
- Shares out
- 166.18M
- Float shares
- 164.82M
Sectors & themes
Quote time 2026-10-08 08:19:26 · For reference only, not investment advice and not tailored to your situation.